News Sentiment

BWAY sentiment intelligence

Brainsway Ltd news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 59 Balanced news tone 60 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 15.06 Week of 10 Jul 2026
Weighted tone 59/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

79/100 classification confidence.

Company focus 48

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend active

-0.9% over one week, +2.9% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

Brainsway (NASDAQ:BWAY) Upgraded to Strong-Buy at Zacks Research

Market Reaction

Balanced read

58/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 79/100 classification
One-week reaction -0.9% Price digesting
Trend fit Trend active 2.9% over four weeks
Fair value 148.0% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 21
Neutral 38
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 48
Industry context 12
Sector context 0

Sources

Coverage mix

Publishers
Market source 16
Stock Titan 10
TradingKey 6
MarketBeat 5
GlobeNewswire 4
Finviz 3
Stock Traders Daily 2
StockStory 2

Event Lens

What the news is about

Classified themes
Market update 30
Earnings 23
Analyst action 3
Guidance 2
Capital return 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 60
MarketBeat Direct company coverage

Brainsway (NASDAQ:BWAY) Upgraded to Strong-Buy at Zacks Research

Zacks Research has upgraded Brainsway (NASDAQ:BWAY) from a "hold" to a "strong-buy" rating, reflecting a generally bullish outlook from analysts. The medical device company, specializing in non-invasive neuromodulation therapies, reported better-than-expected Q1 earnings with EPS

Tone
Positive 82/100
Event
Earnings
Published
15 Jul 2026 10:40
Source
MarketBeat
MarketBeat Direct company coverage

Brainsway (NASDAQ:BWAY) Shares Down 6.8% - Here's Why

Brainsway (NASDAQ:BWAY) shares dropped 6.8% on Monday, closing at $14.04 with significantly lower trading volume. Despite the dip, analyst sentiment remains generally positive, with a "Moderate Buy" consensus rating and an average target price of $16.00. The company recently exce

Tone
Neutral 50/100
Event
Analyst action
Published
13 Jul 2026 14:41
Source
MarketBeat
MarketBeat Direct company coverage

Y.D. More Investments Ltd Raises Stake in Brainsway Ltd. Sponsored ADR $BWAY

Y.D. More Investments Ltd significantly increased its holdings in Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) by 136.6% in the first quarter, now owning 272,004 shares valued at $3.6 million. Other institutional investors also raised stakes, bringing total institutional ownership

Tone
Positive 72/100
Event
Earnings
Published
13 Jul 2026 11:12
Source
MarketBeat
Stock Traders Daily Direct company coverage

Price-Driven Insight from (BWAY) for Rule-Based Strategy

This article provides a price-driven insight for Brainsway Ltd. (NASDAQ: BWAY) focusing on rule-based trading strategies. It highlights a weak near-term sentiment but strong mid and long-term outlooks, with an exceptional risk-reward setup targeting a 32.3% gain. The piece outlin

Tone
Positive 70/100
Event
Market update
Published
11 Jul 2026 22:34
Source
Stock Traders Daily
Finviz Direct company coverage

BWAY - Brainsway Ltd ADR Latest SEC Filings

This page provides detailed financial data and performance metrics for Brainsway Ltd ADR (BWAY), including its latest stock price, changes, market capitalization, income, sales, and various financial ratios. It also presents information on EPS, sales growth, insider and instituti

Tone
Neutral 50/100
Event
Earnings
Published
04 Jul 2026 11:39
Source
Finviz
Finviz Direct company coverage

BWAY - Brainsway Ltd ADR Options

This article provides a detailed financial overview of Brainsway Ltd ADR (BWAY), including its recent stock performance, key financial metrics, and valuation ratios. It lists various indicators such as market capitalization, income, sales, P/E ratio, EPS growth, insider and insti

Tone
Neutral 50/100
Event
Earnings
Published
03 Jul 2026 23:10
Source
Finviz
Finviz Direct company coverage

BWAY - Brainsway Ltd ADR Short Interest

This article provides a detailed financial overview of Brainsway Ltd. (BWAY), an ADR in the medical devices sector. It includes various financial metrics such as market cap, income, sales, P/E ratios, employee count, and stock performance data. Key short interest figures like sho

Tone
Neutral 50/100
Event
Market update
Published
03 Jul 2026 12:10
Source
Finviz
Investing.com South Africa Direct company coverage

Brainsway stock rating reiterated at Buy by H.C. Wainwright on PTSD data

H.C. Wainwright has reiterated a Buy rating and a $17.00 price target for Brainsway (NASDAQ:BWAY) following the presentation of real-world data on its Deep Transcranial Magnetic Stimulation (Deep TMS) treatment for patients suffering from both PTSD and major depressive disorder.

Tone
Positive 74/100
Event
Analyst action
Published
02 Jul 2026 12:12
Source
Investing.com South Africa
TipRanks Direct company coverage

BrainsWay Unveils Strong Real-World Deep TMS Data in Comorbid PTSD and Depression

BrainsWay has released real-world data showing strong efficacy of its Deep TMS in 462 patients with comorbid PTSD and major depressive disorder. The study indicated significant reductions in both PTSD and depression symptoms, suggesting potential benefits for complex psychiatric

Tone
Positive 74/100
Event
Market update
Published
29 Jun 2026 23:09
Source
TipRanks
GlobeNewswire Direct company coverage

BrainsWay Presents Positive Data from Largest Real-World Study of Deep TMS™ in Patients with Comorbid PTSD and Major Depressive Disorder

BrainsWay announced positive real-world data showing significant improvements in patients with comorbid PTSD and Major Depressive Disorder treated with Deep Transcranial Magnetic Stimulation (Deep TMS™). The study, the largest of its kind, found 83.5% of patients responded with a

Tone
Positive 81/100
Event
Market update
Published
29 Jun 2026 22:39
Source
GlobeNewswire
grafa.com Direct company coverage

BrainsWay reports Deep TMS PTSD and depression data

BrainsWay reported positive real-world data from a study of Deep Transcranial Magnetic Stimulation (Deep TMS) in 462 patients with comorbid PTSD and major depressive disorder. The study showed an 83.5% response rate for PTSD and a 66.6% response rate for depression, with a 27.3%

Tone
Positive 72/100
Event
Market update
Published
29 Jun 2026 12:50
Source
grafa.com
Stock Titan Direct company coverage

Deep TMS shows strong PTSD and depression response in BrainsWay (NASDAQ: BWAY) study

BrainsWay Ltd. (NASDAQ: BWAY) announced positive real-world data showing significant improvements in patients with comorbid Post-Traumatic Stress Disorder (PTSD) and Major Depressive Disorder (MDD) treated with Deep Transcranial Magnetic Stimulation (Deep TMS™). A retrospective s

Tone
Positive 70/100
Event
Market update
Published
29 Jun 2026 11:11
Source
Stock Titan
GuruFocus Direct company coverage

BrainsWay Ltd (BWAY) Stock Forecast, Price Targets and Analysts Predictions

This article from GuruFocus provides a stock forecast and price targets for BrainsWay Ltd (BWAY). It outlines key financial metrics such as market cap, enterprise value, P/E ratio, and P/B ratio, along with its GF Score. The article also mentions the availability of analyst ratin

Tone
Positive 61/100
Event
Guidance
Published
28 Jun 2026 21:11
Source
GuruFocus
TradingView Direct company coverage

Price to earnings forward of Brainsway Ltd – TASE:BWAY

This article provides financial context for Brainsway Ltd (TASE:BWAY), specifically focusing on its price-to-earnings forward metric. The content appears to be a stub or a section from a larger financial data platform, showing the company name, stock exchange, and a mention of ma

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 20:12
Source
TradingView
Stock Titan Direct company coverage

Brainsway (BWAY) CTO sells 5,000 shares after exercising options

Brainsway Ltd.'s Chief Technology Officer, Moiseyev Gilad, reported exercising stock options for 7,500 Ordinary Shares on May 25, 2026, and subsequently selling 5,000 Ordinary Shares in an open-market transaction on June 15, 2026, at NIS 42.0397 per share. The company retained 1,

Tone
Neutral 50/100
Event
Market update
Published
22 Jun 2026 20:10
Source
Stock Titan
Investing.com Direct company coverage

BrainsWay expands U.S. insurance coverage for depression treatment

BrainsWay Ltd. announced that eight major payers and the U.S. Department of Veterans Affairs now cover its SWIFT Accelerated Deep TMS protocol, impacting over 57 million lives. This expansion follows a South Carolina policy covering SWIFT, Deep TMS treatment for major depressive

Tone
Positive 70/100
Event
Market update
Published
22 Jun 2026 18:40
Source
Investing.com
Stock Titan Direct company coverage

BrainsWay Reports Favorable Coverage for Accelerated Deep TMS™ Rises to Over 57 Million Covered Lives

BrainsWay (NASDAQ & TASE: BWAY) announced a significant expansion in medical policy coverage for its SWIFT™ Accelerated Deep TMS™ protocol, now covering over 57 million lives in the U.S. This includes a new policy in South Carolina adding 2 million members and broader support fro

Tone
Positive 66/100
Event
Market update
Published
22 Jun 2026 11:09
Source
Stock Titan
Stock Titan Direct company coverage

57M now covered for BrainsWay (NASDAQ: BWAY) accelerated Deep TMS

BrainsWay Ltd. announced a significant expansion in insurance coverage for its SWIFT™ Accelerated Deep TMS™ protocol in the U.S., now covering over 57 million lives. This follows favorable policy changes, including a new policy in South Carolina covering 2 million members. Eight

Tone
Neutral 50/100
Event
Market update
Published
22 Jun 2026 11:09
Source
Stock Titan
Stock Traders Daily Direct company coverage

(BWAY) as a Liquidity Pulse for Institutional Tactics

This article analyzes Brainsway Ltd. (NASDAQ: BWAY) using AI models, highlighting a weak near and mid-term sentiment despite a long-term positive outlook. It provides specific institutional trading strategies, including position trading, momentum breakout, and risk hedging, along

Tone
Positive 66/100
Event
Guidance
Published
19 Jun 2026 20:14
Source
Stock Traders Daily
TradingKey Direct company coverage

Brainsway Ltd (BWAY) Financial Health: Profitability & Balance Sheet Analysis

Brainsway Ltd (BWAY) has a strong financial health score of 8.94, ranking 16th in its industry, indicating robust financial status and high operating efficiency. The company reported a significant year-over-year revenue increase of 34.63% to $15.53 million, and its net profit sur

Tone
Positive 73/100
Event
Earnings
Published
18 Jun 2026 16:40
Source
TradingKey
TradingKey Direct company coverage

Brainsway Ltd (BWAY) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Brainsway Ltd (BWAY), detailing its current earnings forecast score, analyst ratings, and price targets. Brainsway Ltd has an earnings forecast score of 8.67, ranking 17th in its industry, with an average analyst price target of USD

Tone
Positive 72/100
Event
Earnings
Published
18 Jun 2026 16:40
Source
TradingKey
MSN Direct company coverage

Strength Seen in Brainsway (BWAY): Can Its 5.3% Jump Turn into More Strength?

This article from MSN discusses the stock performance of Brainsway (BWAY), noting a recent 5.3% increase. The piece likely delves into whether this upward movement signifies a trend towards further strengthening of the stock. It anticipates analyzing potential factors contributin

Tone
Positive 76/100
Event
Market update
Published
17 Jun 2026 13:09
Source
MSN
TradingKey Direct company coverage

Brainsway Ltd (BWAY) Institutional Confidence

The article analyzes the institutional confidence in Brainsway Ltd (BWAY), noting its current institutional shareholding score of 3.00, which ranks 132nd in the Healthcare Equipment & Supplies industry. It highlights that the institutional shareholding proportion is 30.66%, a 5.6

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 04:09
Source
TradingKey
TradingKey Direct company coverage

Brainsway Ltd (BWAY) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Brainsway Ltd (BWAY), detailing its current price momentum, support and resistance levels, and indicator and moving average readings. Brainsway Ltd's current price momentum score is 7.10, ranking 70 out of 204 in its industry, with th

Tone
Negative 38/100
Event
Market update
Published
17 Jun 2026 04:09
Source
TradingKey
TradingKey Direct company coverage

Brainsway Ltd (BWAY) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a brief overview of Brainsway Ltd (BWAY) revenue breakdown. It shows that in terms of regional revenue, the United States accounts for 81.01% with $33.23M, while "Other" regions contribute 18.99% with $7.79M, totaling $41.02M. The company has not yet disclos

Tone
Neutral 50/100
Event
Earnings
Published
17 Jun 2026 02:40
Source
TradingKey
TradingKey Direct company coverage

Brainsway Ltd (BWAY) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Brainsway Ltd (BWAY)'s dividend and stock split history. It notes that the company has not distributed any dividends in the past five years but does list a stock split event that occurred on February 17, 2026. The page also includes current st

Tone
Neutral 50/100
Event
Capital return
Published
17 Jun 2026 01:40
Source
TradingKey